Furthermore, the high secretion of sEVs from cells expressing oncogenic KIT is partly KIT‐signalling dependent and differs from constitutive EV secretion, which may have implications in the treatment of KIT‐driven diseases such as mastocytosis and GIST in which EVs are thought to contribute to disease pathology. Here, KIT is linked to mastocytosis.